Cancer Institute of New Jersey (CINJ), Pediatric Hematology/Oncology

Fingerprint Dive into the research topics where Cancer Institute of New Jersey (CINJ), Pediatric Hematology/Oncology is active. These topic labels come from the works of this organization's members. Together they form a unique fingerprint.

Precursor Cell Lymphoblastic Leukemia-Lymphoma Medicine & Life Sciences
Methotrexate Medicine & Life Sciences
Pediatrics Medicine & Life Sciences
Hodgkin Disease Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Aminopterin Medicine & Life Sciences
Sickle Cell Anemia Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1992 2019

Precursor Cell Lymphoblastic Leukemia-Lymphoma
Evoked Potentials
Leukemia
Drug Therapy
Brain

Pediatric hodgkin lymphoma: disparities in survival by race

Khullar, K., Rivera-Núñez, Z., Jhawar, S. R., Drachtman, R., Cole, P. D., Hoppe, B. S. & Parikh, R. R., Jan 1 2019, (Accepted/In press) In : Leukemia and Lymphoma.

Research output: Contribution to journalArticle

Hodgkin Disease
Pediatrics
Survival
Proportional Hazards Models
Databases
1 Citation (Scopus)

Response-adapted therapy for the treatment of children with newly diagnosed high risk Hodgkin lymphoma (AHOD0831): a report from the Children’s Oncology Group

Kelly, K. M., Cole, P., Pei, Q., Bush, R., Roberts, K. B., Hodgson, D. C., McCarten, K. M., Cho, S. Y. & Schwartz, C., Oct 1 2019, In : British Journal of Haematology. 187, 1, p. 39-48 10 p.

Research output: Contribution to journalArticle

Hodgkin Disease
Positron-Emission Tomography
Confidence Intervals
Recurrence
Radiotherapy